WHO ICTRP trial
A Prospective, Phase II Study of Neoadjuvant Chemoradiotherapy with Pemetrexed/…
ChiCTR-ONC-12002996 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-ONC-12002996 |
|---|---|
| Public title | A Prospective, Phase II Study of Neoadjuvant Chemoradiotherapy with Pemetrexed/ cisplatin in the Treatment of Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer |
| Scientific title | A Prospective,Phase II Study of Neoadjuvant Chemoradiotherapy with Pemetrexed/ cisplatin in the Treatment of Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer |
| Primary sponsor | Zhejiang Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | II (Phase II study) |
| Conditions | NSCLC |
| Interventions | treatment group:neoadjuvant chemoradiotherapy |
| Registration date | Dec 22, 2012 |
| Target size | treatment group:75 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: